China Inhaler Market Size & Growth Analysis Report, 2019-2025

China inhaler market was valued at around $2.2 billion in 2018 and is anticipated to grow at a substantial rate of 3.3% during the forecast period. High level of air pollution and significant number of smokers in China is boosting the demand for inhalers in the country. Additionally, rising geriatric population susceptible to asthma and COPD within the country is also driving the demand for inhalers. During June 2012 to May 2015, a survey was conducted by the Ministry of Health and Ministry of Science and Technology of China. About 51,000 citizens participated in the survey with 21,500 men and 29,500 women, according to which, it was estimated that about 100 million adults in 2015 had problem of COPD in the country. The prevalence is higher in men as compared to women. As per the estimation, there were 68.4 million men and 31.5 million women affected by COPD.

To Request a Sample of our Report on China Inhaler Market: https://www.omrglobal.com/request-sample/china-inhaler-market

The China inhaler market is segmented on the basis of device, type, application, and end-user. On the basis of device, the market is sub-segmented into metered dosed inhaler, dry powdered inhaler, and nebulizer. The dry powder inhaler is estimated to have largest market share in the China inhaler market due to providing easy inhalation solution. Whereas, the market for metered dose inhaler is estimated to be the fastest growing at a CAGR during the forecast period owing to innovations and collaborations by the companies for the development of metered dosed inhaler. Based on the type, preventive, reliever, and long acting bronchodilators inhaler are analyzed. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

(Get 15% Discount on Buying this Report)

A full Report of China Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/china-inhaler-market

China Inhaler Market Segmentation

By Device

· Metered Dose Inhaler

· Dry Powder Inhaler

· Nebulizer

By Type

· Preventive Inhaler

· Reliever Inhaler

· Long Acting Bronchodilators Inhaler

By Application

· Asthma

· Chronic Obstructive Pulmonary Disease (COPD)

By End-User

· Homecare

· Hospitals and Clinics

Company Profiles

· 3M Co.

· Adherium Ltd.

· Aradigm Corp.

· AstraZeneca PLC

· Boehringer Ingelheim International GmbH

· Cipla Ltd.

· Gerresheimer AG

· GlaxoSmithKline PLC

· Koninklijke Philips N.V.

· Novartis AG

· ResMed Corp.

· Sunovion Pharmaceuticals

· Teva Pharmaceuticals Industries Ltd.

Reasons to Buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-inhaler-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.